Patents matching “insulin”

US 12421280

Insulin like growth factor binding protein bioactive peptide fragments

Northwestern University · Granted Sep 23, 2025 · Expires Sep 18, 2045

US 12325732

Pro-insulin aspart structure and method for preparing insulin aspart

AMPHASTAR NANJING PHARMACEUTICALS INC · Granted Jun 10, 2025 · Expires Jun 5, 2045

US 12226437

Method for enhancing expression of insulin like growth factor 1 receptor in umbilical cord mesenchymal stem cell expressing IGF1R and method for obtaining multipotent umbilical cord mesenchymal stem cell

China Medical University · Granted Feb 18, 2025 · Expires Feb 13, 2045

US 11974989

Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

VTV THERAPEUTICS LLC · Granted May 7, 2024 · Expires May 2, 2044

US 11859020

Insulin like growth factor binding protein bioactive peptide fragments

Northwestern University · Granted Jan 2, 2024 · Expires Dec 28, 2043

US 11844867

Method of delivering insulin into a lumen of the intestinal tract using a swallowable drug delivery device

Rani Therapeutics, LLC · Granted Dec 19, 2023 · Expires Dec 14, 2043

US 11833136

Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

VTV THERAPEUTICS LLC · Granted Dec 5, 2023 · Expires Nov 30, 2043

WO 2023183767

MÉTHODES ET COMPOSITIONS POUR AUGMENTER LA SENSIBILITÉ À L'INSULINE

ABBOTT LAB [US] · Granted Sep 28, 2023 · Expires Sep 23, 2043

US 11708416

Methods of treating severe insulin resistance by interfering with glucagon receptor signaling

REGENERON PHARMACEUTICALS, INC. · Granted Jul 25, 2023 · Expires Jul 20, 2043

US 11666637

Insulin-loaded metal-organic frameworks

Northwestern University · Granted Jun 6, 2023 · Expires Jun 1, 2043

WO 2023076144

MÉTHODES ET COMPOSITIONS DESTINÉES À AMÉLIORER LA PRODUCTION ET LA SÉCRÉTION D'INSULINE

ABBOTT LAB [US] · Granted May 4, 2023 · Expires Apr 29, 2043

US 11602556

Insulin mimotopes and methods of using the same

The Regents of the University of Colorado, a Body Corporate · Granted Mar 14, 2023 · Expires Mar 9, 2043

US 11555055

Peptide inhibitors of insulin-degrading enzyme

The Regents of the University of California · Granted Jan 17, 2023 · Expires Jan 12, 2043

US 11529373

Method for enhancing expression of insulin like growth factor 1 receptor in mesenchymal stem cell, method for obtaining mesenchymal stem cell, and method for treating brain tissue damage

China Medical University · Granted Dec 20, 2022 · Expires Dec 15, 2042

US 11524987

Highly purified recombinant human insulin (RHI) API and methods of producing the same

Amphastar Pharmaceuticals, Inc. · Granted Dec 13, 2022 · Expires Dec 8, 2042

CA 3213326

METHODES ET COMPOSITIONS POUR AMELIORER LA PRODUCTION ET LA SECRETION D'INSULINE

ABBOTT LAB [US] · Granted Oct 6, 2022 · Expires Oct 1, 2042

US 11446360

High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same

Amphastar Pharmaceuticals, Inc. · Granted Sep 20, 2022 · Expires Sep 15, 2042

US 11066670

Insulin-like growth factor binding protein, acid labile subunit (IGFALS) and insulin-like growth factor 1 (IGF-1) iRNA compositions and methods of use thereof

Alnylam Pharmaceuticals, Inc. · Granted Jul 20, 2021 · Expires Jul 15, 2041

US 11028061

Modulators of myocyte lipid accumulation and insulin resistance and methods of use thereof

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Jun 8, 2021 · Expires Jun 3, 2041

US 10995146

Methods of treating severe insulin resistance by interfering with glucagon receptor signaling

REGENERON PHARMACEUTICALS, INC. · Granted May 4, 2021 · Expires Apr 29, 2041

US 10980749

Therapeutic preparation comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Rani Therapeutics, LLC · Granted Apr 20, 2021 · Expires Apr 15, 2041

US 10952993

Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

VTV THERAPEUTICS LLC · Granted Mar 23, 2021 · Expires Mar 18, 2041

US 10688063

Treating and/or preventing insulin-resistance related weight gain

The United States Government as Represented by the Department of Veterans Affairs of General Counsel- PSG IV (024) · Granted Jun 23, 2020 · Expires Jun 18, 2040

US 10660918

Method for enhancing insulin like growth factor 1 receptor expression of mesenchymal stem cell, method for isolating mesenchymal stem cell, and use of mesenchymal stem cell

China Medical University · Granted May 26, 2020 · Expires May 21, 2040